11/19
04:05 pm
cdxs
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
Low
Report
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
11/19
08:08 am
cdxs
Biofuel Enzyme Global Market Overview 2024: Blending Mandates and Bioethanol Adoption Fueling the $2.5 Billion Market - Forecasts to 2030 [Yahoo! Finance]
Medium
Report
Biofuel Enzyme Global Market Overview 2024: Blending Mandates and Bioethanol Adoption Fueling the $2.5 Billion Market - Forecasts to 2030 [Yahoo! Finance]
11/15
10:27 am
cdxs
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Low
Report
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
11/14
04:17 pm
cdxs
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics [Yahoo! Finance]
Medium
Report
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics [Yahoo! Finance]
11/14
04:05 pm
cdxs
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
Medium
Report
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
11/12
04:05 pm
cdxs
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
Low
Report
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
11/11
04:15 pm
cdxs
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics [Yahoo! Finance]
Low
Report
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics [Yahoo! Finance]
11/11
04:05 pm
cdxs
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
Low
Report
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
11/8
04:05 pm
cdxs
Codexis Announces New Employment Inducement Grants
Low
Report
Codexis Announces New Employment Inducement Grants
11/4
04:19 pm
cdxs
Codexis to Participate in Upcoming Healthcare Conferences [Yahoo! Finance]
Medium
Report
Codexis to Participate in Upcoming Healthcare Conferences [Yahoo! Finance]
11/4
04:05 pm
cdxs
Codexis to Participate in Upcoming Healthcare Conferences
Medium
Report
Codexis to Participate in Upcoming Healthcare Conferences
11/4
08:19 am
cdxs
Codexis, Inc. (NASDAQ: CDXS) had its "hold" rating re-affirmed by analysts at Benchmark Co..
Low
Report
Codexis, Inc. (NASDAQ: CDXS) had its "hold" rating re-affirmed by analysts at Benchmark Co..
11/3
08:39 am
cdxs
Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17 [Yahoo! Finance]
Low
Report
Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17 [Yahoo! Finance]
11/2
09:29 am
cdxs
Codexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Codexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
10/31
04:05 pm
cdxs
Codexis Reports Third Quarter 2024 Financial Results
High
Report
Codexis Reports Third Quarter 2024 Financial Results
10/24
04:05 pm
cdxs
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
Low
Report
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
10/14
07:51 pm
cdxs
Industrial Enzymes Market to Grow by USD 2.25 Billion from 2024-2028, AI Driving Market Transformation and Rising Demand for Food Enzymes Boosting Revenue - Technavio [Yahoo! Finance]
Medium
Report
Industrial Enzymes Market to Grow by USD 2.25 Billion from 2024-2028, AI Driving Market Transformation and Rising Demand for Food Enzymes Boosting Revenue - Technavio [Yahoo! Finance]
10/14
07:05 am
cdxs
Codexis Announces New Employment Inducement Grants
Low
Report
Codexis Announces New Employment Inducement Grants
10/10
04:05 pm
cdxs
Codexis to Report Third Quarter 2024 Financial Results on October 31
Medium
Report
Codexis to Report Third Quarter 2024 Financial Results on October 31
10/2
04:05 pm
cdxs
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
Low
Report
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
10/1
07:07 am
cdxs
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences [Yahoo! Finance]
Medium
Report
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences [Yahoo! Finance]
10/1
07:05 am
cdxs
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
Medium
Report
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
9/20
12:19 pm
cdxs
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Low
Report
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
9/7
11:10 am
cdxs
Pleasing Signs As A Number Of Insiders Buy Codexis Stock [Yahoo! Finance]
Medium
Report
Pleasing Signs As A Number Of Insiders Buy Codexis Stock [Yahoo! Finance]
9/6
04:05 pm
cdxs
Codexis Announces New Employment Inducement Grants
Medium
Report
Codexis Announces New Employment Inducement Grants